ArticleAsthma research and practice2020

Continuous versus intermittent short-acting β2-agonists nebulization as first-line therapy in hospitalized children with severe asthma exacerbation: a propensity score matching analysis.

Prapasri Kulalert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.